Dubow Adam
- SEC CIK
- 0001744507
In the past year, 2 open-market sale filings worth $112.7K and no purchases.
Current role at each company
- DAWN Day One Biopharmaceuticals, Inc.Gen Counsel & Secretaryas of Apr 23, 2026
- BMY Bristol Myers Squibb CoSVP,ChiefCompliance&EthicsOff.as of Aug 3, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $112.7K
- 2 filings
- Net
- −$112.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Dubow Adam as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DAWN Day One Biopharmaceuticals, Inc.
Gen Counsel & Secretary10 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 (view filing) | Feb 17 | 1 day | Dubow AdamGen Counsel & Secretary | SSale | −6.39K | $11.60 | −$74.2K | −8.1%72.7K after | |
| Nov 18, 2025 (view filing) | Nov 17 | 1 day | Dubow AdamGen Counsel & Secretary | SSale | −4.32K | $8.91 | −$38.5K | −6.5%62.6K after | |
| Aug 19, 2025 (view filing) | Aug 18 | 1 day | Dubow AdamGen Counsel & Secretary | SSale | −4.37K | $6.77 | −$29.6K | −7.4%54.9K after | |
| May 19, 2025 (view filing) | May 16 | 3 days | Dubow AdamGENERAL COUNSEL | SSale | −4.55K | $6.26 | −$28.5K | −8.8%47.1K after | |
| Feb 21, 2025 (view filing) | Feb 18 | 3 daysLate | Dubow AdamGENERAL COUNSEL | SSale | −4.65K | $11.96 | −$55.6K | −10.5%39.6K after | |
| Nov 19, 2024 (view filing) | Nov 18 | 1 day | Dubow AdamGENERAL COUNSEL | SSale | −3.17K | $13.21 | −$41.8K | −9.0%32.2K after | |
| Aug 19, 2024 (view filing) | Aug 16 | 3 days | Dubow AdamGENERAL COUNSEL | SSale | −3.20K | $14.00 | −$44.8K | −10.6%26.9K after | |
| May 17, 2024 (view filing) | May 16 | 1 day | Dubow AdamGENERAL COUNSEL | SSale | −3.25K | $16.08 | −$52.3K | −13.0%21.7K after | |
| Feb 20, 2024 (view filing) | Feb 16 | 4 days | Dubow AdamGENERAL COUNSEL | SSale | −3.24K | $15.25 | −$49.4K | −16.4%16.6K after | |
| Nov 17, 2023 (view filing) | Nov 16 | 1 day | Dubow AdamGeneral Counsel | SSale | −5.31K | $11.69 | −$62.1K | −31.7%11.4K after |
BMY Bristol Myers Squibb Co
SVP,ChiefCompliance&EthicsOff.1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2021 (view filing) | Jul 30 | 4 days | Dubow AdamSVP,ChiefCompliance&EthicsOff. | SSaleCommon Stock, $0.10 par value | −2.47K | $67.90 | −$167.4K | −15.2%13.8K after |